Co announces its partner, Keryx Biopharmaceuticals (KERX) presented a poster outlining Phase 1 and Phase 2 results for perifosine, an oral anti-cancer signal transduction inhibitor compound, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results